These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19098487

  • 1. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M, Puigdomènech I, Cabrera C, Fernandez-Figueras MT, Aucher A, Gaibelet G, Hudrisier D, García E, Bofill M, Clotet B, Blanco J.
    AIDS; 2009 Jan 14; 23(2):183-8. PubMed ID: 19098487
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.
    Bosch B, Grigorov B, Senserrich J, Clotet B, Darlix JL, Muriaux D, Este JA.
    Antiviral Res; 2008 Nov 14; 80(2):185-93. PubMed ID: 18602423
    [Abstract] [Full Text] [Related]

  • 4. HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection.
    Clotet-Codina I, Bosch B, Senserrich J, Fernández-Figueras MT, Peña R, Ballana E, Bofill M, Clotet B, Esté JA.
    Antiviral Res; 2009 Jul 14; 83(1):94-8. PubMed ID: 19501262
    [Abstract] [Full Text] [Related]

  • 5. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.
    Scherer EM, Zwick MB, Teyton L, Burton DR.
    AIDS; 2007 Oct 18; 21(16):2131-9. PubMed ID: 18090039
    [Abstract] [Full Text] [Related]

  • 6. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS, Pattenden LK, Fletcher JM, Castanho MA, Aguilar MI.
    Chembiochem; 2009 Apr 17; 10(6):1032-44. PubMed ID: 19283693
    [Abstract] [Full Text] [Related]

  • 7. Inefficient human immunodeficiency virus replication in mobile lymphocytes.
    Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O.
    J Virol; 2007 Jan 17; 81(2):1000-12. PubMed ID: 17079292
    [Abstract] [Full Text] [Related]

  • 8. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
    Burrer R, Haessig-Einius S, Aubertin AM, Moog C.
    Virology; 2005 Mar 01; 333(1):102-13. PubMed ID: 15708596
    [Abstract] [Full Text] [Related]

  • 9. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, Barin F, Costagliola D, Caumes E, Clauvel JP, Autran B, Musset L, ALT ANRS CO15 Study Group.
    Clin Infect Dis; 2009 Jan 01; 48(1):123-32. PubMed ID: 19035778
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
    Lekkerkerker AN, Ludwig IS, van Vliet SJ, van Kooyk Y, Geijtenbeek TB.
    Virology; 2004 Nov 24; 329(2):465-76. PubMed ID: 15518824
    [Abstract] [Full Text] [Related]

  • 12. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V, Costagliola D, Simon A, Debré P, French Asymptomatiques à Long Terme (ALT) Study Group.
    AIDS; 2006 Sep 11; 20(14):1795-804. PubMed ID: 16954720
    [Abstract] [Full Text] [Related]

  • 13. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P, Costagliola D, Legrand R, Vieillard V.
    Bull Acad Natl Med; 2009 Jan 11; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [Abstract] [Full Text] [Related]

  • 14. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA, Koff WC.
    Science; 2004 Jun 25; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract] [Full Text] [Related]

  • 15. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
    Bunnik EM, Lobbrecht MS, van Nuenen AC, Schuitemaker H.
    Virology; 2010 Feb 05; 397(1):224-30. PubMed ID: 19945135
    [Abstract] [Full Text] [Related]

  • 16. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
    Molina L, Grimaldi M, Robert-Hebmann V, Espert L, Varbanov M, Devaux C, Granier C, Biard-Piechaczyk M.
    Proteomics; 2007 Sep 05; 7(17):3116-30. PubMed ID: 17676665
    [Abstract] [Full Text] [Related]

  • 17. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
    Huskens D, Van Laethem K, Vermeire K, Balzarini J, Schols D.
    Virology; 2007 Apr 10; 360(2):294-304. PubMed ID: 17123566
    [Abstract] [Full Text] [Related]

  • 18. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
    Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA.
    Virology; 2005 Dec 20; 343(2):256-66. PubMed ID: 16278001
    [Abstract] [Full Text] [Related]

  • 19. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K, Zhang Y, Xu J, Yu Q, Tam JP.
    Biopolymers; 2008 Dec 20; 90(3):320-9. PubMed ID: 18338371
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.
    Cicala C, Arthos J, Censoplano N, Cruz C, Chung E, Martinelli E, Lempicki RA, Natarajan V, VanRyk D, Daucher M, Fauci AS.
    Virology; 2006 Feb 05; 345(1):105-14. PubMed ID: 16260021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.